1. [Management of a global health crisis: first COVID-19 disease feedback from Overseas and French-speaking countries medical biologists].
- Author
-
Barguil Y, Chiaradia L, Sicard D, Duhin M, Sebat C, Abdi S, Alomar Y, Blondeel N, Bonnet C, Bouberi-Niava B, Bourgoin-Rousset E, Cavalier E, Cisse F, Combe P, de Guire V, Devaud F, De Wulf A, Agne FD, Dumas-Chastang E, Ecrabey YC, Grignon JC, Gruson D, Gueye PM, Hayette MP, Kabré E, Kandji PM, Kouakou HF, Legris-Allusson V, Lim S, Monde A, Monnet D, Forton GN, Outreville J, Padelli M, Sakandé J, Sall A, Subiros M, Tayeb N, Temmar A, Thiam S, Ting Wang H, Bérard AM, Piéroni L, Sapin V, and Beauvieux MC
- Subjects
- Adult, Africa epidemiology, Aged, Aged, 80 and over, Belgium epidemiology, Betacoronavirus physiology, Biomarkers analysis, Biomarkers blood, COVID-19, Cambodia epidemiology, Child, Contact Tracing methods, Contact Tracing statistics & numerical data, Coronavirus Infections transmission, Diagnosis, Differential, Female, France epidemiology, Hospitalization statistics & numerical data, Humans, Infant, Newborn, Islands epidemiology, Language, Laos epidemiology, Louisiana epidemiology, Male, Medical Laboratory Personnel organization & administration, Medical Laboratory Personnel statistics & numerical data, Middle Aged, Pandemics, Pneumonia, Viral transmission, Retrospective Studies, SARS-CoV-2, Surveys and Questionnaires, Survival Analysis, Travel Medicine methods, Travel Medicine statistics & numerical data, Travel-Related Illness, Tropical Climate, Tropical Medicine methods, Tropical Medicine organization & administration, Tropical Medicine statistics & numerical data, Vietnam epidemiology, Clinical Laboratory Services organization & administration, Clinical Laboratory Services statistics & numerical data, Coronavirus Infections diagnosis, Coronavirus Infections epidemiology, Coronavirus Infections therapy, Global Health statistics & numerical data, Pneumonia, Viral diagnosis, Pneumonia, Viral epidemiology, Pneumonia, Viral therapy, Travel Medicine organization & administration
- Abstract
The French society of clinical biology "Biochemical markers of COVID-19" has set up a working group with the primary aim of reviewing, analyzing and monitoring the evolution of biological prescriptions according to the patient's care path and to look for markers of progression and severity of the disease. This study covers all public and private sectors of medical biology located in metropolitan and overseas France and also extends to the French-speaking world. This article presents the testimonies and data obtained for the "Overseas and French-speaking countries" sub-working group made up of 45 volunteer correspondents, located in 20 regions of the world. In view of the delayed spread of the SARS-CoV-2 virus, the overseas regions and the French-speaking regions have benefited from feedback from the first territories confronted with COVID-19. Thus, the entry of the virus or its spread in epidemic form could be avoided, thanks to the rapid closure of borders. The overseas territories depend very strongly on air and/or sea links with the metropolis or with the neighboring continent. The isolation of these countries is responsible for reagent supply difficulties and has necessitated emergency orders and the establishment of stocks lasting several months, in order to avoid shortages and maintain adequate patient care. In addition, in countries located in tropical or intertropical zones, the diagnosis of COVID-19 is complicated by the presence of various zoonoses (dengue, Zika, malaria, leptospirosis, etc.).
- Published
- 2020
- Full Text
- View/download PDF